Brivaracetam
NDC 84386-071, Brivaracetam, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 84386-071
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214848
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/84386-071 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM75 mg/1
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84386-071-60 | 84386007160 | 60 TABLET, FILM COATED in 1 BOTTLE (84386-071-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/59817617-956e-4685-81d4-7abe42f4de86
Use it
Look up 84386-071 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84386-071 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84386-071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.